Mori T, Cui L, Kato K, Takahashi S, Imaida K, Iwasaki S, Ito N, Shirai T
First Department of Pathology, Nagoya City University Medical School, Nagoya, Japan.
Jpn J Cancer Res. 1996 Jun;87(6):570-4. doi: 10.1111/j.1349-7006.1996.tb00261.x.
The present experiment was carried out to explore the effect of endogenous androgen on rat prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB) and testosterone propionate (TP) or 5alpha-dihydrotestosterone (DHT) with or without ethinyl estradiol (EE). In order to eliminate the influence of endogenous androgen, F344 rats were orchiectomized just after initiation with the prostate carcinogen, DMAB, and then given TP, DHT, TP plus EE or DHT plus EE for 40 weeks. The results demonstrated that while administration of TP following DMAB treatment causes invasive carcinomas in the lateral and anterior prostate and seminal vesicles, DHT does not exhibit equivalent effects. Synergistic enhancement was also evident with TP plus EE, but not with DHT plus EE. The incidences of prostatic and seminal vesicle lesions in all groups of the present experiment, except for the group given castration without hormonal supplement, were equivalent to those previously found in non-castrated animals. Therefore, the present findings indicate that endogenous testosterone may not be required for promotion by TP/EE of DMAB-initiated prostate carcinogenesis and that it may not contribute to the actions of DHT.
本实验旨在探究内源性雄激素对由3,2'-二甲基-4-氨基联苯(DMAB)和丙酸睾酮(TP)或5α-双氢睾酮(DHT)单独或联合乙炔雌二醇(EE)诱导的大鼠前列腺癌发生的影响。为消除内源性雄激素的影响,F344大鼠在开始给予前列腺致癌物DMAB后即行去势手术,然后给予TP、DHT、TP加EE或DHT加EE,持续40周。结果表明,DMAB治疗后给予TP可导致前列腺外侧叶、前叶及精囊出现浸润性癌,而DHT未表现出同等作用。TP加EE也有协同增强作用,但DHT加EE则无。本实验所有组(除单纯去势未补充激素组外)前列腺及精囊病变的发生率与之前在未去势动物中发现的发生率相当。因此,本研究结果表明,TP/EE促进DMAB引发的前列腺癌发生可能不需要内源性睾酮,且内源性睾酮可能对DHT的作用无贡献。